Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Ambrosia Biosciences recently secured a massive $100 million in an oversubscribed Series B financing round. Blue Owl Healthcare Opportunities, Redmile, and Deep Track Capital co-led this pivotal investment. This backing signals strong market confidence in Ambrosia’s innovative metabolic disease treatments.…
Structure Therapeutics reported that its new weight loss pill produced a 16.3% drop in body weight. Patients taking the 180 mg daily dose lost about 39 pounds over 44 weeks. Notably, the study found that patients kept losing weight throughout…
The landscape of weight-loss medications is changing rapidly right now. For years, people have relied almost entirely on frequent injections to manage their weight. Now, new oral therapies are finally making their way to the market. Novo Nordisk recently introduced…
The Food and Drug Administration (FDA) has authorized oral semaglutide, expanding GLP-1 treatment beyond injections. These tablets add options for chronic weight management and glycemic control in type 2 diabetes. As of February 2026, Wegovy tablets and two oral diabetes…